First Eagle Investments started to build up the position in Amedisys in Q1 2022 and continued to invest until Q1 2023. Since then they sold 101 Thousand shares. The investor completely sold their stake between Q2 2023 and Q4 2024.
Avg closing price
Price range
Sold -2.1 Thousand shares
Q4 2024
Avg closing price
$91.69
Price range
$83.52
-
$97.71
Sold 40.5% shares (-1.43 Thousand shares)
Q3 2024
Avg closing price
$97.57
Price range
$96.51
-
$98.45
Sold 86.0% shares (-21.8 Thousand shares)
Q1 2024
Avg closing price
$93.71
Price range
$92.15
-
$95.24
Sold 64.9% shares (-46.9 Thousand shares)
Q4 2023
Avg closing price
$93.40
Price range
$91.15
-
$95.90
Sold 4.5% shares (-3.43 Thousand shares)
Q3 2023
Avg closing price
$92.41
Price range
$89.84
-
$94.08
Sold 25.4% shares (-25.8 Thousand shares)
Q2 2023
Avg closing price
$82.04
Price range
$73.99
-
$92.60
Increased shares by 71.9% (+42.4 Thousand shares)
Q1 2023
Avg closing price
$86.52
Price range
$69.79
-
$100.33
Increased shares by 110.2% (+30.9 Thousand shares)
Q4 2022
Avg closing price
$90.16
Price range
$80.12
-
$105.34
Increased shares by 12.0% (+3.01 Thousand shares)
Q3 2022
Avg closing price
$119.25
Price range
$96.79
-
$131.14
Increased shares by 19932.0% (+24.9 Thousand shares)
Q2 2022